48
Participants
Start Date
April 8, 2019
Primary Completion Date
December 26, 2019
Study Completion Date
December 26, 2019
Imvanex
Imvanex 0.5 milliliter (mL) suspension for injection will be administered as single subcutaneous (SC) injection.
Shingrix
Shingrix 0.5 mL suspension will be administered as single intramuscular (IM) injection.
LPS
LPS 1.0 nanogram per kilogram (ng/kg) endotoxin suspension will be administered as single IV injection.
Candin
Candin 0.1 mL solution for injection will be administered as one intradermal injection.
Skin Biopsy
3 punch biopsies will be performed and lower abdomen tissue biopsy specimens will be collected on Day 1.
Saline Control
Saline control solution for injection will be administered as one intradermal injection.
Clinical Pharmacology Unit, Merksem
Janssen Research & Development, LLC
INDUSTRY